The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
MCMDA: Matrix completion for MiRNA-disease association prediction
Open accessAbstract
// Jian-Qiang Li 1, * , Zhi-Hao Rong 2, * , Xing Chen 3 , Gui-Ying Yan 4 , Zhu-Hong You 5 1 College of Computer Science and Software Engineering, Shenzhen University, Shenzhen, 518060, China 2 School of Software, Beihang University, Beijing, 100191, China 3 School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, 221116, China 4 Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China 5 Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Science, ÜRÜMQI, 830011, China * The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint first authors Correspondence to: Xing Chen, email: xingchen@amss.ac.cn Keywords: miRNA, disease, miRNA-disease association, matrix completion Received: October 17, 2016 Accepted: January 09, 2017 Published: February 03, 2017 ABSTRACT Nowadays, researchers have realized that microRNAs (miRNAs) are playing a significant role in many important biological processes and they are closely connected with various complex human diseases. However, since there are too many possible miRNA-disease associations to analyze, it remains difficult to predict the potential miRNAs related to human diseases without a systematic and effective method. In this study, we developed a Matrix Completion for MiRNA-Disease Association prediction model (MCMDA) based on the known miRNA-disease associations in HMDD database. MCMDA model utilized the matrix completion algorithm to update the adjacency matrix of known miRNA-disease associations and furthermore predict the potential associations. To evaluate the performance of MCMDA, we performed leave-one-out cross validation (LOOCV) and 5-fold cross validation to compare MCMDA with three previous classical computational models (RLSMDA, HDMP, and WBSMDA). As a result, MCMDA achieved AUCs of 0.8749 in global LOOCV, 0.7718 in local LOOCV and average AUC of 0.8767+/-0.0011 in 5-fold cross validation. Moreover, the prediction results associated with colon neoplasms, kidney neoplasms, lymphoma and prostate neoplasms were verified. As a consequence, 84%, 86%, 78% and 90% of the top 50 potential miRNAs for these four diseases were respectively confirmed by recent experimental discoveries. Therefore, MCMDA model is superior to the previous models in that it improves the prediction performance although it only depends on the known miRNA-disease associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Scarecrow-like mRNA Targets Directed by a Class of Arabidopsis miRNA
Llave, C., Xie, Z., Kasschau, K. D., & Carrington, J. C. (2002) · Science · doi:10.1126/science.1076311 · Cited by 1,627
Cited by
MicroRNAs and complex diseases: from experimental results to computational models
Chen, X., Xie, D., Zhao, Q., & You, Z.-H. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx130 · Cited by 638
Self-citationPredicting miRNA–disease association based on inductive matrix completion
Chen, X., Wang, L., Qu, J., Guan, N.-N., & Li, J.-Q. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty503 · Cited by 467
Self-citationChen, X., Yin, J., Qu, J., & Huang, L. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006418 · Cited by 350
Self-citationLi, J., Zhang, S., Liu, T., Ning, C., Zhang, Z., & Zhou, W. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz965 · Cited by 350
Self-citationEGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction
Chen, X., Huang, L., Xie, D., & Zhao, Q. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0003-x · Cited by 275
Self-citation
Metadata
- Authors
- Li, J.-Q., Rong, Z.-H., Chen, X., Yan, G.-Y., & You, Z.-H.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-02-03
- Volume
- 8
- Issue
- 13
- Pages
- 21187-21199
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2584926544
- Cited by
- 196
- References
- 1
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.